Skip to content

Pharminent

cropped-ChatGPT-Image-Jun-16-2026-01_58_09-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Regulatory
  • FDA, Moderna appear aligned on mRNA flu shot heading into adcomm
  • Regulatory

FDA, Moderna appear aligned on mRNA flu shot heading into adcomm

BioSpace

The Vaccines and Related Biological Products Advisory Committee will meet June 18 to discuss Moderna's seasonal flu vaccine mRNA-1010 after the FDA initially refused to accept the application in Febru

Infectious Disease

Read full story

pharminent June 16, 2026

BioSpace

The Vaccines and Related Biological Products Advisory Committee will meet June 18 to discuss Moderna’s seasonal flu vaccine mRNA-1010 after the FDA initially refused to accept the application in Febru

Infectious Disease

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: German said to be backtracking on pharma rebate changes
Next: Next Post

Related Stories

  • Regulatory

FDA and MHRA forge new regulatory collaboration initiative

pharminent June 16, 2026
  • Regulatory

FDA clears MSD’s Keytruda combo plus Welireg for ccRCC treatment

pharminent June 15, 2026
  • Regulatory

Novo Nordisk comeback stirs as Wegovy pill wins UK approval

pharminent June 12, 2026

You May Have Missed

  • Manufacturing

pharminent June 17, 2026
wp_daily_digest_2026-06-17
  • News

pharminent June 17, 2026
  • M&A / Deals

Jazz orchestrates a $4bn cancer alliance with AbCellera

pharminent June 17, 2026
  • Clinical Data

Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short

pharminent June 17, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.